Why insider trading matters?
Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology in Israel, the United States, and internationally. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for a functional cure of chronic hepatitis B. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the target virus to elicit a potent immune response. It primarily serves physicians and pharmacists through direct sales. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-12-03 | Beattie Nell | Chief Business Officer | Buy | 8,200 | $2.45 | $20,083 | No |
| 2021-12-01 | PERCEPTIVE ADVISORS LLC | 10%-Owner | Sell | 2,707,463 | $3.31 | $8,961,703 | No |
| 2021-06-29 | PERCEPTIVE ADVISORS LLC | 10%-Owner | Sell | 646,257 | $3.80 | $2,455,777 | No |
| 2021-06-09 | PERCEPTIVE ADVISORS LLC | 10%-Owner | Sell | 1,422,567 | $4.00 | $5,690,268 | Yes |
| 2020-04-24 | PERCEPTIVE ADVISORS LLC | 10%-Owner | Buy | 9,090,909 | $1.10 | $10,000,000 | No |
| 2019-10-04 | Diaz-Mitoma Francisco | Chief Medical Officer | Buy | 54,500 | $0.50 | $27,250 | No |
| 2019-10-01 | McNulty Christopher | CFO and Head of BD | Buy | 12,000 | $0.47 | $5,676 | No |
| 2019-10-01 | Beattie Nell | Chief Business Officer | Buy | 10,000 | $0.48 | $4,822 | No |
| 2019-09-30 | Baxter Jeff | CEO, President | Buy | 150,000 | $0.50 | $75,450 | No |
| 2019-09-23 | PERCEPTIVE ADVISORS LLC | 10%-Owner | Buy | 20,000,000 | $0.50 | $10,000,000 | No |
| 2019-06-27 | Diaz-Mitoma Francisco | Chief Medical Officer | Buy | 8,000 | $1.07 | $8,560 | No |
| 2019-06-20 | Diaz-Mitoma Francisco | Chief Medical Officer | Buy | 52,000 | $0.87 | $45,180 | No |
| 2019-06-18 | PERCEPTIVE ADVISORS LLC | 10%-Owner | Buy | 1,000,000 | $0.65 | $650,000 | No |
| 2019-06-19 | Beattie Nell | Chief Business Officer | Buy | 8,000 | $0.74 | $5,886 | No |
| 2019-06-19 | Baxter Jeff | CEO, President | Buy | 144,000 | $0.73 | $105,336 | No |
| 2019-06-17 | PERCEPTIVE ADVISORS LLC | 10%-Owner | Buy | 1,000,000 | $0.62 | $618,000 | No |
| 2018-12-17 | Kariv Tomer | Director | Buy | 1,428,571 | $1.40 | $1,999,999 | No |
| 2018-12-13 | PERCEPTIVE ADVISORS LLC | 10%-Owner | Buy | 14,285,714 | $1.40 | $20,000,000 | No |
| 2018-08-06 | Baxter Jeff | CEO, President | Buy | 8,100 | $1.93 | $15,607 | No |
| 2018-08-03 | Diaz-Mitoma Francisco | Chief Medical Officer | Buy | 9,000 | $2.13 | $19,200 | No |
| 2018-08-03 | Baxter Jeff | CEO, President | Buy | 13,500 | $2.01 | $27,111 | No |
| 2018-08-03 | Beattie Nell | Chief Business Officer | Buy | 2,000 | $2.01 | $4,011 | No |
| 2018-07-31 | Baxter Jeff | CEO, President | Buy | 16,800 | $2.28 | $38,237 | No |
| 2018-05-24 | Baxter Jeff | CEO, President | Buy | 11,000 | $2.99 | $32,890 | No |
| 2018-05-11 | Diaz-Mitoma Francisco | Chief Medical Officer | Buy | 10,000 | $3.05 | $30,475 | No |
| 2018-05-11 | Baxter Jeff | CEO, President | Buy | 7,100 | $2.91 | $20,661 | No |
| 2017-12-12 | Baxter Jeff | CEO, President | Buy | 10,000 | $3.89 | $38,854 | No |
| 2017-11-28 | Baxter Jeff | CEO, President | Buy | 15,000 | $4.75 | $71,250 | No |
| 2017-10-30 | Opko Health, Inc. | 10%-Owner | Buy | 655,738 | $3.05 | $2,000,001 | No |
| 2017-10-30 | GILLIS STEVEN | Director | Buy | 300,000 | $3.05 | $915,000 | No |
Insider Smart
Insider Smart